ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,680.29
0.56%
Dow Jones
41,841.63
0.85%
Gold vs US Dollar
3,006.215
0.18%
Brent Oil
70.965
0.43%
Bitcoin
83,340.00
-0.85%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Alterity Therapeutics Ltd (PK) (PRNAF)

  7. Alterity Therapeutics Ltd (PK) (PRNAF) News

Alterity Therapeutics (PK) (PRNAF)

Alterity Therapeutics Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PRNAF
DateTimeSourceHeadlineSymbolCompany
28/02/202512:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
28/02/202512:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/02/202511:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/02/202511:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/02/202513:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/02/202512:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
10/02/202512:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
10/02/202512:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
28/01/202511:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/01/202513:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/01/202513:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
21/01/202511:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/12/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/10/202412:48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
23/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
15/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/10/202410:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
30/09/202410:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:40Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
20/09/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
03/09/202410:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
01/08/202411:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/07/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/07/202410:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/07/202410:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/07/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
 Showing the most relevant articles for your search:USOTC:PRNAF

Your Recent History

USOTC
ABXXF
Abaxx Technologies (QX)
AMEX
DXN
BIT
LNIK
ETFS 2x Daily Long Nickel
TG
EV00
Evoke Pharma
NASDAQ
DISCB
Discovery
TG
EIBB
Invesco Markets II
ASX
EYM
TG
4EG0
Englobal
ASX
NPMO
NewPeak Metals
LSE
38IN
Lloyds Bk
NASDAQ
GNLN
Greenlane
AMEX
ELR
TSXV
SAG
Sterling Metals
TG
CE8G
Amundi Msci World Ex Eur...
CSE
PACT
Impact Analytics
USOTC
PSFT
Powersafe Technology (CE)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads